What Matters Most: The Trends That Will Shape Pharma Marketing in 2023

In our eighth annual trends forecast, dozens of experts from EVERSANA and EVERSANA INTOUCH explain the five issues pharma marketers will need to address in 2023.

Read More

Scroll down

More Industry Blogs

09|19|23

Pharma Needs To Stop Apologizing! Looking for Progress At Digital Pharma East.

Missed DPE 2023? Check out our assessment of the event and what pharma marketers should consider in their day-to-day.

09|14|23

Digital Medicine in Pharma: A Marketers’ Guide for Launch, Promotion and Life Cycle Management

Beyond the pill, there are treatments that pharma marketers are launching, promoting and managing throughout their life cycle. Check out this POV, for a guide on marketing digital medicine in pharma.

09|13|23

Promotional Medical Education: It’s Not What It Used to Be

Promotional medical education includes traditional tactics that have worked for decades, but smart brands know that today, it also comprises more advanced educational elements as well as novel ways to deliver information. We explain and give examples in this latest blog.

09|07|23

Re-Imagining Promotional Medical Education: A New POV

Too many marketers have an outdated idea of what promotional medical education is. In this new POV, we explain what it can be - and what it can do - today!

08|28|23

How Pharma Brands Grow: Branding in a Performance Marketing World

Get new research insights and learn what makes a pharma brand grow in a world of brand and performance marketing.

08|25|23

What the Success of “Barbie” Means for Women’s Health

In a recent article for PharmaLive.com and Med Ad News, Elizabeth Rooney, Managing Director, Executive Creative Director, EVERSANA INTOUCH urges all healthcare marketers to make the most of "Barbie" grabbing the cultural zeitgeist to make a difference for women's health.

08|10|23

Accelerating Rare Disease Patient Engagement

Industry challenges in rare disease create an opportunity for brand marketers to advance patient engagement. Check out this POV to learn more.

08|01|23

Modern MedComms: Translating Science into Engagement (for Today’s HCP)

Digital tech and the medical landscape have both changed enormously in recent years. As a result, so too has pharma marketing. But unfortunately, too many medical communications efforts still rely on the 20th century, and as a result, fail to make an impact on brands. Medical communications (MedComms), or promotional peer-to-peer education, is an essential […]

07|26|23

Why Market Access Matters to Marketers More Than Ever

Payer marketing, reimbursement strategy, payer engagement, market access – whatever term your organization might use, optimizing your brand value and communicating that value to your stakeholders is a vital discipline. Because in our healthcare ecosystem, what gets paid for gets done… and what doesn’t get paid for often doesn’t get done. Payer controls on brands […]

07|18|23

Threading the Needle: Is Meta’s Threads Headed for Success?

Will Meta's new Threads matter to pharma advertisers? When will we know if it's a success? We give you answers from Justin Chase, EVP, EVERSANA INTOUCH Media, along with recent news coverage with his expertise.

Load More Posts